New guidelines aim to improve Type 1 Diabetes care for millions
More than 9.5 million people worldwide were living with type 1 diabetes in 2025, but many still struggle to access affordable insulin and essential healthcare, prompting the World Health Organization (WHO) to issue its first guidelines on diagnosing and managing the condition in adults.
Released ahead of World Diabetes Day 2026, the guidelines provide recommendations for improving treatment and care across different healthcare settings, including countries with limited resources and areas affected by emergencies and humanitarian crises.
Type 1 diabetes is a lifelong condition in which the pancreas produces little or no insulin, a hormone the body needs to regulate blood glucose levels. People living with the condition depend on daily insulin treatment to survive.
According to WHO, approximately 500,000 additional people were diagnosed with type 1 diabetes in 2025. Although the condition has traditionally been associated with children, an increasing number of adults are also being diagnosed.
“Insulin is a lifesaving treatment, discovered more than 100 years ago. Yet many people with type 1 diabetes do not have access to affordable and high-quality insulin,” said Dr Søren Brostrøm, WHO Director of Noncommunicable Diseases and Mental Health.
He said the new guidelines provide evidence-based recommendations to help countries improve care, including in settings where healthcare resources are limited or services have been disrupted.
The guidelines recommend that people with type 1 diabetes receive multiple insulin injections daily, with doses adjusted according to their blood glucose levels.
WHO identifies human insulin, a manufactured medicine that works similarly to insulin naturally produced by the body, as an effective treatment option. Other types of insulin can also be used when necessary.
The recommendations also emphasise regular blood glucose monitoring to help patients and healthcare professionals manage the condition.
Monitoring can include laboratory tests that measure average blood glucose levels over several months, as well as home-based methods such as finger-prick blood tests and continuous glucose monitoring devices. The latter use small sensors worn on the skin to track glucose levels.
Where blood glucose testing is unavailable, WHO says urine glucose testing can be considered as an alternative.
The guidelines are also intended to support countries in achieving WHO targets for 2030, which include ensuring that everyone living with type 1 diabetes has access to affordable insulin treatment and blood glucose self-monitoring.
WHO said it would support countries in implementing the recommendations by providing practical tools and guidance to monitor progress. Governments are also encouraged to involve people living with type 1 diabetes in designing, implementing and evaluating national diabetes programmes.
This year’s World Diabetes Day is being observed under the theme “Early action on diabetes”, highlighting the importance of timely diagnosis and treatment to prevent complications.
Diabetes can cause serious health problems, including blindness, kidney failure, heart attacks, strokes and lower-limb amputations.
WHO estimates that the number of people living with diabetes worldwide has more than quadrupled since 1990. In 2022, approximately 830 million people were living with the condition, most of them with type 2 diabetes.
More than 40% of people with diabetes are unaware that they have the condition, leaving them undiagnosed and potentially delaying access to treatment and care.
About The Author

SUBSCRIBE TO OUR NEWSLETTER